{"datasetJSONCreationDateTime":"2024-11-11T15:09:23","datasetJSONVersion":"1.1.0","fileOID":"Covance Laboratories/Study8326556-Define2-XML_2.0.0/2024-11-11/tx","dbLastModifiedDateTime":"2019-10-03T10:03:31","originator":"CDISC SEND Team","sourceSystem":{"name":"SAS on X64_10PRO","version":"9.0401M7"},"studyOID":"8326556","metaDataVersionOID":"CDISC-SEND.3.1","metaDataRef":"define.xml","itemGroupOID":"IG.TX","records":6,"name":"TX","label":"Trial Sets","columns":[{"itemOID":"IT.TX.STUDYID","name":"STUDYID","label":"Study Identifier","dataType":"string","length":7,"keySequence":1},{"itemOID":"IT.TX.DOMAIN","name":"DOMAIN","label":"Domain Abbreviation","dataType":"string","length":2},{"itemOID":"IT.TX.SETCD","name":"SETCD","label":"Set Code","dataType":"string","length":1,"keySequence":2},{"itemOID":"IT.TX.SET","name":"SET","label":"Set Description","dataType":"string","length":4},{"itemOID":"IT.TX.TXSEQ","name":"TXSEQ","label":"Sequence Number","dataType":"integer"},{"itemOID":"IT.TX.TXPARMCD","name":"TXPARMCD","label":"Trial Set Parameter Short Name","dataType":"string","length":8,"keySequence":3},{"itemOID":"IT.TX.TXPARM","name":"TXPARM","label":"Trial Set Parameter","dataType":"string","length":33},{"itemOID":"IT.TX.TXVAL","name":"TXVAL","label":"Trial Set Parameter Value","dataType":"string","length":36}],"rows":[["8326556","TX","1","Dose",1,"ARMCD","Arm Code","1"],["8326556","TX","1","Dose",2,"SPGRPCD","Sponsor-Defined Group Code","1"],["8326556","TX","1","Dose",3,"GRPLBL","Group Label","G1 - Hepatitis B Vaccine: 20 ug/dose"],["8326556","TX","1","Dose",4,"TRTDOS","Dose Level","20"],["8326556","TX","1","Dose",5,"PLANFSUB","Planned Number of Female Subjects","4"],["8326556","TX","1","Dose",6,"TRTDOSU","Dose Units","ug/dose"]]}